(123)i-meta-iodobenzylguanidine
(123)i-mibg
6 min walk test
6-min walk test
6-minute hall walk
6-minute walk distance
6-minute walk test
6-minute walked distance
6-minute walking distance
6-mwt
6mwt
8-fluo-camp
a comparison of outcomes in patients in new york heart association [nyha] class ii heart failure when treated with eplerenone or placebo in addition to standard heart failure medicines
aa
abcc2
abcd classification
abdominal
ablation
absorptiometry
acetylcholinesterase inhibitor
acute
acute coronary syndrome
adenosine
adenoviral
adenovirus
adenylyl cyclase
adjusted odds ratio
adjuvant
admission
admissions
adrenergic
adrenomedullin
adverse event
adverse outcome
aetiologies
afterload
akt→forkhead box class o-1 signaling
alberta
albumin
aldactone
aldosterone
aldosterone receptor
all-cause hospitalisations
all-cause hospitalization
all-cause hospitalizations
all-cause readmission
all-cause readmissions
allogeneic
alphalisa
ambulatory
american college of physicians
amyloidotic
anabolic
anastomosis
anesthetized
ang ii
angiotensin
angiotensin converting enzyme
angiotensin ii  infusion
angiotensin receptor antagonist
angiotensin-converting enzyme
angiotensin-receptor blocker
ann arbor veterans' affairs
annular ms
antagomir
antagonism
antagonist
anterior leaflet
anthracyclines
anti-inflammatory
antiadrenergic
antiarrhythmic
antibodies
antiplatelet medication
antitachycardia pacing
antitumor
aor
aortic
aortic pressure
aortic valve
area under the curve
area under the receiver operating characteristic curve
arg16/gln27
arg76
arrhythmias
arterial
arterial pressure
arterial tonometry
arteries
artery
artery tonometry
arthritis
asymptomatic
at1
atherosclerotic
atpase
atrial
atrial explants
atrial pacing
atrioventricular
atrium
atropine
attrition
aucs
autologous
autonomic imbalance
b natriuretic peptides
b-type natriuretic peptide
b-type natriuretic peptides
baroreflex
baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction
basic helix-loop-helix
benign tumors
bet
beta-adrenergic receptor
beta-adrenergic responses
beta-blocker
biomedical
biopsies
biopsy
bisphosphonate
biventricular
blood
blood cell
blood flow
blood glucose
blood-flow
bone morphogenetic protein 4
bp
bpm
brachial systolic pressure
bradycardia
bradycardic
brain
brd4
breathing
breathlessness
bromodomain
bromodomain-containing protein 4
bundle branch block
bundle branch morphology
bypass
c statistics
c-kit+ cell
c-kit+ progenitors
c-terminally
ca(2+)
ca(2+) sensitivity
ca2(+)
ca2+
cabg
cachectic heart failure
calcineurin
california
california office of statewide health planning and development patient discharge data nonpublic file
camp hydrolysis
camp signaling
canada
candesartan
candesartan in heart failure assessment of reduction in mortality and morbidity
carcinoma
cardiac deaths
cardiac defibrillator
cardiac disease
cardiac energy metabolism gene expression
cardiac event
cardiac failure
cardiac metabolic gene expression
cardiac mrna
cardiac plasma membrane
cardiac progenitor function
cardiac remodelling
cardiac sodium
cardiac transplants
cardiac volume
cardiac washout
cardiogenic
cardiography
cardiology-cardiovascular surgery consensus report
cardiomyiopathy
cardiomyocyte
cardiomyopathic
cardiomyopathies
cardioprotective
cardiopulmonary bypass
cardiovascular event
cardiovascular morbidity
cardiovascular outcomes in renal atherosclerotic lesions
cardioverter defibrillators
cardioverter-defibrillator
carotid
carotid intima-media thickness
case-fatality rate
caspase
catabolic
catecholamine
catecholamines
catheter
catheterisation
catheterization
cell death
cells
cellular metabolism
central end-systolic pressure
central glycosylated region
centrimag
cerebral
cerebrovascular
chamber
charm
cha₂ds₂vasc score
chelation
chest
chf-nyha-ii
china
cholesterol
chronic advanced heart failure
chronic organ failure
chronic thromboembolic pulmonary hypertension
chronotropic response
circulation
circulatory
circumferential strain
circumflex artery
citrate cycle
city of hope
clinic
clinical practice guideline
clinical practice guidelines
clinically
clinician
clinicians
cluster analysis
co-morbidity
co-primary outcome
coagulability
cochrane
cochrane effective practice and organisation of care taxonomy
cohort studies
cohort study
collagen
collins
combined end point
comorbid
comorbidity
compensatory hypertrophy
compliance
composite end point
composite end-point
composite primary outcome
concentric left ventricular hypertrophy
condition
conditions
confidence intervals
congenital
congestive hf
connecticut
consultation
contemporaneous control group
continuity equation
contractile
contractile response
contracting
cooper center longitudinal study
coprimary outcome
coronary
coronary arteries
coronary artery
coronary artery bypass
coronary revascularization
correlate
correlated
correlates
correlation
correlation coefficient
correlations
covariate
covariate adjustment
covariates
cox modeling
cox proportional hazards analyses
cpet
cpg
creatine
cri
cronbach's α
cross talk
cross-talk
crossover study
curative
cxl-1051
cyclase
cyclic guanosine monophosphate
cystatin c
cytoskeleton
cytotoxic
dapc protein
david
deaths
decompensated heart failure
decompensation
defibrillation
defibrillators
denervation
descriptive statistics
dhand
diabetic
diagnoses
diagnostic
dialysis
diastolic
diastolic mitral annular velocity
diastolic mitral annulus velocity
diastolic murmurs
diastolic stiffness
diastolic tethering
differential analysis
differential effect
differentially expressed genes
dilatation
dilated
dilation
discharged
discharges
disease
diseased
diseases
dodson
donors
doppler
downregulated
doxorubicin efflux transporter
driveline
drs
drug
drug treatment
duke activity status index
e/e'
early treatment of atrial fibrillation for stroke prevention trial
echo-derived pulmonary arterial systolic pressure
echo-doppler
edema
eds
edwards lifesciences
effector molecules
electrocardiogram
electrocardiographic
embolectomy
embolism
embolize
emergency room
end point
end points
end stage heart failure
end-diastolic
end-diastolic pressure
end-point
end-stage hf
end-systolic
end-systolic volume
endopeptidase
endopeptidase inhibitors
endothelial
endpoint
endpoints
enos-ser(1177)
enos-thr(495)
enzyme
enzymes
eo-cfu
epicatechin
epidemic
epithelial
eplerenone post myocardial infarction heart failure efficacy and survival study
erk1/2
erythropoiesis
erythropoiesis-stimulating agent
esc
estimated glomerular filtration rate
etiologic
etiologies
europe
european society of cardiology
evidence-based
explant
explanted
explants
exploratory factor analysis
expression
expressions
extended criteria cardiac transplant
extended criteria cardiac transplantation
extracellular
fat free mass
fat-free mass
fibrillation
filling pressure
fluid overload
fluid retention
fluorescence resonance energy transfer
follow up
follow-up duration
followed up
followed-up
fontan
framingham heart study
fully magnetically levitated centrifugal-flow chronic lvas
fully magnetically levitated left ventricular assist system
functional class
furosemide
g-protein coupling
g-protein-coupled receptor
gadolinium-chelate
gadolinium-chelate contrast agent
gata4
gene
gene expression
gene expression profile
gene expressions
gene induction
general anaesthesia
genes
genomic
genomic reprogramming
genotype
genotyped
get with the guideline-heart failure registry
get with the guidelines-heart failure
glucocorticoid
glucocorticoids
gluconeogenesis
gly16/glu27
gly4
gly7
grade 4/6 holosystolic murmur
grading of recommendations assessment, development and evaluation
gse9128
gtpase
guanylate cyclase
guideline-directed medical therapy
h-dko
haematopoietic
hand2
haplotype
health
health care
health-care
health-related quality of life
healthcare
healthcare common procedure coding system codes
healthy
heart  failure
heart beat
heart failure - a controlled trial investigating outcomes in exercise training
heart failure adherence and retention trial
heart failure and reduced ejection fraction
heart failure survey
heart failure with a reduced ejection fraction
heart failure with preserved ejection fraction
heart failure with preserved left ventricular ejection fraction
heart failure with reduced ejection fraction
heart failure: a controlled trial investigating outcomes of exercise training
heart function clinic
heart iron
heart mass
heart muscle
heart sound
heart-specific irs1 and irs2 gene double-knockout
hemodynamics
hemolysis
hepatic
hf index
hf with preserved ef
hf with preserved ejection fraction
hf with reduced ef
hf with reduced ejection fraction
high-density lipoprotein
histological
histologically
homozygous
hospital anxiety and depression scale
hospital-to-home
hospitalisations
human-to-human contact
human-to-machine interface
hvad
hypertensive heart failure with preserved ejection fraction
hypertrophic
hypertrophied
hyponatremia
hypothermic circulatory arrest
icd
icu
idiopathic
immunoassays
immunoreactive
implant
implantable
implantable cardioverter defibrillator
implantation
implantations
implanted
implants
in vitro
in vivo
incidence
incremental shuttle walk test
infarct
infarcted
infection
infusion
infusions
ingenuity pathway analysis
inhospital
injected
injections
inoperable
inpatient
insignificantly
insulin
insulin receptor substrates 1
insulin-resistance
intensive care
intensive care unit
intention-to-treat
interatrial
interatrial shunting
interleukin receptor
intermacs
internists
interventricular
interventricular septum
intestinal
intracellular
intramuscular testosterone supplementation
intravenous
intravenous bolus
intravenously
intubated
intubation
invasive
invasive haemodynamic assessment
invasive hemodynamic assessments
invasively
inverse correlation
irvine
ischaemia
ischemic cerebrovascular events
ischemic hf
isoforms
isolated coronary artery bypass grafting
isoprenaline
israel
joanna briggs institute
joanna briggs institute evidence based practice
jugular
kaiser permanente
kansas city
kappa coefficients
kcl-ki
kidney
kidney disease
kinase
kinase-2
kv4.3
l-type ca2(+) current
l-type channel
l-type voltage-gated ca(2+) channels
lcz696
leaflet
left anterior descending artery
left anterior descending coronary artery occlusion
left atrial
left atrial pressure
left atrium
left bundle branch block pattern
left bundle-branch block
left pulmonary artery
left ventricular ejection fractions
left ventricular function
left ventricular hypertrophy
lesion
lesions
leu3
leukocytes
life expectancy
likelihood ratio
linear mixed models
linear models
lipid
liver
liver-specific irs1 and irs2 double-knockout
log rank
logistic regression
lokomat
long axis function
longitudinal
lung
lv contractile function
lv contractility
lv mass
lv posterior wall
lv relaxation
lvh
magnet
mapk
mass spectrometric analysis
maximal ventricular power index
maximum oxygen consumption
medicaid
medical
medical history
medical outcomes study short-form
medically
medicine
medicines
mena deletion
mesenchymal
meta-analyses
meta-analysis
meta-analyzed
metabolic
metabolic pathways
mets
michigan
microarray
microembolization
mild hf
minimal detectable change
minnesota quality of life
mis
mitochondrial
mitochondrial proteome
mitochondrial-targeted peptide
mitochondrial-targeted peptides
mitogen-activated protein kinase
mitral
mitral annular velocity
mitral annulus velocity
mitral leaflet motions
mitral valve
mitral valve area
mixed models
mixed-methods study
molecular scaffolds
morbidities
morpholino-based
mpsms
mrna
mrna splice
mrnas
multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy
multivariable adjustment
multivariable analysis
multivariable logistic analysis
multivariable models
multivariable regression
multivariate analyses
multivariate analysis
multivariate cox model
multivariate cox proportional hazards regression modeling
multivariate logistic regression analysis
multivariate model
multivariate models
multivariate regression
multivariate-adjusted odds ratio
murine
muscle
muscles
muscular
myocardial
myocardial angiogenesis
myocardial fibrosis
myocardial tissue
myocardial tissues
myocardial washout
myoctyes
myocyte differentiation
myocyte hypertrophy
myocyte-specific mena overexpression
myofibrillar
myofilament
myosin
myxoma
n-terminal pro-brain-type natriuretic peptide
n2bus
na+ channel
na+ channel α-subunit
na+ channels
nad(p)h-oxidase
nanog
nanomolar
narrow qrs complex
national cardiovascular disease registry practice innovation and clinical excellence registry
natremia
natriuretic
ncdr pinnacle
neprilysin
neprilysin inhibitor
net reclassification improvement
net-reclassification-improvement
neuro-hormonal
neurohormonal
neurohormonal systems
neurohormonally
neurohumoral
new jersey
new york
new york heart association class i
new york heart association classes
new zealand
noc
nodularity
non-invasively
non-ischemic heart failure
noncardiovascular
nondiabetes
nondiabetic
noninvasive
nonischemic
nonmitochondrial
nonmitochondrial protein
nonselective β-blocker
nonsignificant
nonterminal epitopes
north america
northern california
nosignificant
nri
nris
nt-pro bnp
nuclear factor of activated t cells
nurse
nurse practitioner
nurses
nursing
nyha class iiib
nyha functional class iii
nyha-ii
nyha-iii
observational cohort studies
observational cohort study
odds ratio
oedema
ontario
ontario case costing initiative
operation
operations
operative
or
oral
orally
organ
organ failure
organic
osteomedullary biopsy
out-patient
outpatient
p value
p values
p-value
p38alpha
p38α
p70s6k-ser(411)
paco2
palliation
palliative
papillary muscles
partial pressure of end-tidal co2
pathobiology
pathological
pathology
pathophysiologic
pathophysiological
pathophysiologically
paucity
pde
pdrelated
peak early diastolic mitral annular velocity
peak o2
peak respiratory quotient
pediatric fontan
peptide
peptides
perceived social support score
percutaneous
periodic breathing
perioperative
peripheral muscle
petco2
pevk
pharmaceutically
pharmaceuticals
pharmacologic
pharmacological
phenotype
phenotypes
phenylephrine
phosphomimic
physical
physical examination
physician
physiologic
physiological
physiology
pkc-βii-ser(660)
plasma catecholamines
pluripotency marker
pluripotency markers
poc
point of care
point-of-care
pol ii
polymerase ii
polymorphism
polytetrafluoroethylene
positron emission tomography
post hoc analysis
post-myocardial infarction
postcontrast t1
postischemic heart failure
postmenopausal
postoperative
postoperatively
postsystolic function
precapillary pulmonary hypertension
preoperative
prescribed
prescribing
prescription
preserved left ventricular ejection fractions
pressure volume relation
pressure-overload
prevalence
primary composite endpoint
primary end point
primary endpoint
primary outcome
primary outcomes
pro bnp
pro-b-type natriuretic peptide
pro-b-type natriuretic peptides
pro-b-type np
pro-brain natriuretic peptide
pro-brain-type natriuretic peptide
pro2
pro6
pro75
proangiogenic
proanp
probnp
prodrug
progenitor
progenitor cells
progenitors
prognostic
prognostically
proof-of-principle cohort study
propensity-score
prospective
prospective studies
prospective study
prospectively
protein
protein kinase a
protein-c
proteolysis
proteomic
psychometric
psychosocial
pubmed
pulmonary arterial pressure
pulmonary artery systolic pressure
pulmonary embolectomy
pulmonary resistance
pulse
pulse-wave
pump dysfunction
q65p
qt interval
quality-of-life
québec
québec health insurance board
r
r-r interval
rac1
radiological
raft
rales
randomised
randomization
randomize
randomized
randomized aldactone evaluation study
rankin score
ras-blocker
rate ratio
receptor
receptors
red blood cell
red blood cell transfusion
reduced left ventricular ejection fraction
refractory right heart failure
regression analyses
regression analysis
regression line
regression modeling
regression models
rehabilitation
relative risk
rem
remodelling
remote ischemic conditioning
renastur
renin
renin inhibitors
renin-angiotensin-aldosteron
reperfusion
repolarization
resuscitation
resynchronization
resynchronization reverses remodeling in systolic left ventricular dysfunction
resynchronization therapy
retn
retrospective matched cohort study
rgk proteins
rheumatic
rheumatoid
right atrial
right atrial pressure
right atrium
right heart
right pulmonary artery
right ventricle
right ventricular assist device
right ventricular assist devices
right ventricular contractile function
right ventricular dysfunction
right ventricular ejection fraction
right ventricular end-diastolic area index
right ventricular fractional area
right ventricular pacing
right ventricular pressure overload
right ventricular-pulmonary arterial coupling
rna
rnas
rotterdam study
rs10927887
rv decompensation
rvads
s'
s12884
s3991
sacubiltril
sarcomere
sarcopenic range muscle wasting
scaffold proteins
sd of all qt intervals
sd of rr intervals
seattle
second-generation sulfonylureas
secondary end point
secondary end points
secondary endpoints
secondary outcome
secondary outcomes
seer-medicare
selective β-blocker
self-care of heart failure index version 6.2
septal
ser77
ser83
ser96
serum albumin
serum creatinine
serum potassium
serum sodium
severe hf
severe systolic heart failure
severe systolic hf
shotgun lc-ms/ms
shunt
shunting
shunts
signal transduction
signaling pathway
signalling pathway
significance
significant
significantly
snp
sonographic
south dakota
specificity
sphingosine-1-phosphate receptor 1
sprague-dawley
ss
ss31
st-segment-elevation mis
stable
stable heart failure
stem cell
stenosis
stenotic physiology
stent
sternal
sternotomy
stroke volume index
strokes
structured telephone support
subcellular
subclinical
subproteome
subproteomes
subvalvular
surgeons
surgical
surgical palliation
surgically
sweden
sympathetic control of heart rate
symptom
symptomatic
symptomatic chronic advanced heart failure
symptomatic systolic heart failure
symptoms
syndromes
systemic
systolic  heart failure
systolic heart failure treatment with the if inhibitor ivabradine trial
systolic left ventricular dysfunction
systolic volume index
t1
t1 time
t1 times
t1-mapping
t2*
tachyarrhythmias
tachycardic
telemonitoring
terminal
terminal heart failure
testosterone
texas
texas cancer registry–medicare
tgf-β receptor type i
thalassaemia major
the chronic kidney disease epidemiology collaboration
the danish heart failure database
the lancet
therapeutics
third heart sound
thr197
thromboembolic
thromboembolic pulmonary hypertension
thromboembolism
thrombotic
timed up & go test
tissue doppler
tissuefaxs
titin
titrated
tm24/7
tnf
tomographic angiography
tonometric
tonometry
tools for economic analysis of patient management interventions in heart failure cost-effectiveness model
toronto
total arterial compliance
transcription factor
transfusion
transgenic
transmitral
transmitral blood flow velocity
transmitral flow
transplantations
transseptal
trichrome blue histologic analysis
tricuspid
tricuspid annular plane
troponin
troponin i
trpm7
tta/tgtetmena
tug
tumor
tumors
turkey
type i regulatory subunit
u.s. food and drug administration's mini-sentinel
ulcers
undiagnosed
unilateral renal denervation
united states
univariable analysis
univariate analysis
university health network
university of connecticut
university of michigan
uptitration
uptitrations
urinary tract infection
us
use of exercise and medical therapies to improve cardiac function among patients with exertional shortness of breath due to lung congestion
valsartan
vascular
vascular disease
vascular diseases
vascular endothelial growth factor
vasodilator
vasodilatory
vasopressin type 2 receptor antagonist
vegf expression
vegf inhibition
vegf pathway
vegf receptor
ven/vco2 slope
vena cava
venoarterial dilation
venous
venous thromboembolic events
venous thromboembolism
ventricles
ventricular action potential
ventricular fibrillation
ventricular function
ventricular myocytes
ventricular systolic hf
ventricular tachycardia
ventricularly
vo2 max
von willebrand factor
vt
wall stiffness
western australia
wide qrs complex
wilcoxon matched-pairs signed-rank tests
wistar-kyoto
women's health initiative
world health organization
x-ray
yorkshire
z-score
zsf1
β-adrenergic receptor
β-adrenergic receptor blocker
β-myosin heavy chain
β2-receptor haplotype
